Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

384 ARTÍCULOS , VIENDO DEL 121 AL 135

Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons: Case Reports and Review of the Literature

Wangensteen KJ, Krawitt EL, Hamill RW, Boyd JT.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):1-5. doi: 10.1097/WNF.0000000000000120.

Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies

Ali SA, Yin N, Rehman A, Justilien V.

Med Sci (Basel). 2016 Jan 20;4(1):1. doi: 10.3390/medsci4010001.

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's Disease

Miyazaki I, Asanuma M.

Curr Med Chem. 2016;23(7):686-700. doi: 10.2174/0929867323666160122115057.

Molecular imaging of dopamine transporters

Brooks DJ.

Ageing Res Rev. 2016 Sep;30:114-21. doi: 10.1016/j.arr.2015.12.009. Epub 2016 Jan 21.

Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature

Wilke C, Pomper JK, Biskup S, Puskás C, Berg D, Synofzik M.

J Neurol. 2016 Mar;263(3):558-74. doi: 10.1007/s00415-016-8021-7. Epub 2016 Jan 25.

Early-onset Parkinson's Disease Associated with Chromosome 22q11.2 Deletion Syndrome

Oki M, Hori S, Asayama S, Wate R, Kaneko S, Kusaka H.

Intern Med. 2016;55(3):303-5. doi: 10.2169/internalmedicine.55.5485. Epub 2016 Feb 1.

Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients

Rusz J, Tykalová T, Klempíř J, Čmejla R, Růžička E.

J Neural Transm (Vienna). 2016 Apr;123(4):379-87. doi: 10.1007/s00702-016-1515-8. Epub 2016 Feb 3.

Nonmotor features of Parkinson's disease subtypes

Marras C, Chaudhuri KR.

Mov Disord. 2016 Aug;31(8):1095-102. doi: 10.1002/mds.26510. Epub 2016 Feb 10.

Age at onset and Parkinson disease phenotype

Pagano G, Ferrara N, Brooks DJ, Pavese N.

Neurology. 2016 Apr 12;86(15):1400-1407. doi: 10.1212/WNL.0000000000002461. Epub 2016 Feb 10.

Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait

Fleury V, Pollak P, Gere J, Tommasi G, Romito L, Combescure C, Bardinet E, Chabardes S, Momjian S, Krainik A, Burkhard P, Yelnik J, Krack P.

Mov Disord. 2016 Sep;31(9):1389-97. doi: 10.1002/mds.26545. Epub 2016 Feb 17.

Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication

Murakami H, Momma Y, Nohara T, Mori Y, Futamura A, Sugita T, Ishigaki S, Katoh H, Kezuka M, Ono K, Miller MW, Kawamura M.

J Parkinsons Dis. 2016;6(1):209-17. doi: 10.3233/JPD-150702.

Comorbidity between neurological illness and psychiatric disorders

Hesdorffer DC.

CNS Spectr. 2016 Jun;21(3):230-8. doi: 10.1017/S1092852915000929. Epub 2016 Feb 22.

Vocal tract characteristics in Parkinson's disease

Gillivan-Murphy P, Carding P, Miller N.

Curr Opin Otolaryngol Head Neck Surg. 2016 Jun;24(3):175-82. doi: 10.1097/MOO.0000000000000252.

Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders

Calabria FF, Calabria E, Gangemi V, Cascini GL.

Hell J Nucl Med. 2016 Jan-Apr;19(1):33-41. doi: 10.1967/s002449910335. Epub 2016 Mar 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias